BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36069598)

  • 1. A Closer Look at the Laboratory Impact of Utilizing ePlex Blood Culture Identification Panels: a Workflow Analysis Using Rapid Molecular Detection for Positive Blood Cultures.
    Tansarli GS; Chapin KC
    Microbiol Spectr; 2022 Oct; 10(5):e0179622. PubMed ID: 36069598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel.
    Carroll KC; Reid JL; Thornberg A; Whitfield NN; Trainor D; Lewis S; Wakefield T; Davis TE; Church KG; Samuel L; Mills R; Jim P; Young S; Nolte FS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31996444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Broad-Panel PCR-Based Bacterial Identification for Blood Cultures in a Pediatric Oncology Population.
    Garner CD; Brazelton de Cardenas J; Suganda S; Hayden RT
    Microbiol Spectr; 2021 Sep; 9(1):e0022121. PubMed ID: 34232100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ePlex Blood Culture Identification Panels for Detection of Pathogens in Bloodstream Infections.
    Huang TD; Melnik E; Bogaerts P; Evrard S; Glupczynski Y
    J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30487304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical impact of implementing GenMark ePlex blood culture panels for around-the-clock blood culture identification; a prospective observational study.
    Krifors A; Rådberg G; Golbob S; Omar Z; Svensson C; Heimer D; Carlander C
    Infect Dis (Lond); 2020 Oct; 52(10):705-712. PubMed ID: 32522111
    [No Abstract]   [Full Text] [Related]  

  • 6. A Multicenter Clinical Study To Demonstrate the Diagnostic Accuracy of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel.
    Wolk DM; Young S; Whitfield NN; Reid JL; Thornberg A; Carroll KC; Buchan BW; Davis TE; Salimnia H
    J Clin Microbiol; 2021 Aug; 59(9):e0248420. PubMed ID: 34232066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test Performance and Potential Clinical Utility of the GenMark Dx ePlex Blood Culture Identification Gram-Negative Panel.
    McCarty TP; Cumagun P; Meeder J; Moates D; Edwards WS; Hutchinson J; Lee RA; Leal SM
    Microbiol Spectr; 2023 Feb; 11(1):e0409222. PubMed ID: 36688641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Microbiological Performance and the Potential Clinical Impact of the ePlex
    Bryant S; Almahmoud I; Pierre I; Bardet J; Touati S; Maubon D; Cornet M; Richarme C; Maurin M; Pavese P; Caspar Y
    Front Cell Infect Microbiol; 2020; 10():594951. PubMed ID: 33324578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Clinical Utility of Rapid Diagnostics for Treatment of Bloodstream Infections Using Desirability of Outcome Ranking Approach for the Management of Antibiotic Therapy (DOOR-MAT).
    Claeys KC; Hopkins TL; Schlaffer K; Hitchcock S; Jiang Y; Evans S; Johnson JK; Leekha S
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0044121. PubMed ID: 34228533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of early detection of ESBL-producing Enterobacterales with PCR-based blood culture assays.
    Chang KM; Haghamad A; Saunders-Hao P; Shaffer A; Mirsaidi N; Zimilover A; Epstein M; Jain S; Streva V; Juretschko S; Demissie S; Gautam-Goyal P
    Am J Infect Control; 2024 Jan; 52(1):73-80. PubMed ID: 37544512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical performance and potential clinical utility of the GenMark Dx ePlex® blood culture identification gram-positive panel.
    McCarty TP; White CM; Meeder J; Moates D; Pierce HM; Edwards WS; Hutchinson J; Lee RA; Leal SM
    Diagn Microbiol Infect Dis; 2022 Nov; 104(3):115762. PubMed ID: 35988351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two rapid molecular test systems to establish an algorithm for fast identification of bacterial pathogens from positive blood cultures.
    Oberhettinger P; Zieger J; Autenrieth I; Marschal M; Peter S
    Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1147-1157. PubMed ID: 32020397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of ePlex® blood culture identification panels in clinical isolates and characterization of antimicrobial stewardship opportunities.
    Thomas JK; Clark J; Arora V; Burgess DS; Burgess DR; Mynatt RP; VanHoose JD; Wallace KL; Cotner SE
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116269. PubMed ID: 38692201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter Evaluation of the FilmArray Blood Culture Identification 2 Panel for Pathogen Detection in Bloodstream Infections.
    Caméléna F; Péan de Ponfilly G; Pailhoriès H; Bonzon L; Alanio A; Poncin T; Lafaurie M; Dépret F; Cambau E; Godreuil S; Chenouard R; Le Monnier A; Jacquier H; Berçot B
    Microbiol Spectr; 2023 Feb; 11(1):e0254722. PubMed ID: 36519852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Evaluation of a PCR-Based Digital Microfluidics and Electrochemical Detection System for the Rapid Identification of 15 Fungal Pathogens Directly from Positive Blood Cultures.
    Zhang SX; Carroll KC; Lewis S; Totten M; Mead P; Samuel L; Steed LL; Nolte FS; Thornberg A; Reid JL; Whitfield NN; Babady NE
    J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32075904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of novel rapid diagnostic of blood culture identification and antimicrobial susceptibility testing by Accelerate Pheno system and BioFire FilmArray Blood Culture Identification and BioFire FilmArray Blood Culture Identification 2 panels.
    Sze DTT; Lau CCY; Chan TM; Ma ESK; Tang BSF
    BMC Microbiol; 2021 Dec; 21(1):350. PubMed ID: 34922463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Impact of the Expanded BioFire Blood Culture Identification 2 Panel in a U.S. Children's Hospital.
    Graff KE; Palmer C; Anarestani T; Velasquez D; Hamilton S; Pretty K; Parker S; Dominguez SR
    Microbiol Spectr; 2021 Sep; 9(1):e0042921. PubMed ID: 34431685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of peptide nucleic acid fluorescence in situ hybridization assays with culture-based matrix-assisted laser desorption/ionization-time of flight mass spectrometry for the identification of bacteria and yeasts from blood cultures and cerebrospinal fluid cultures.
    Calderaro A; Martinelli M; Motta F; Larini S; Arcangeletti MC; Medici MC; Chezzi C; De Conto F
    Clin Microbiol Infect; 2014 Aug; 20(8):O468-75. PubMed ID: 24304149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Evaluation of the Accelerate Pheno System for Susceptibility Testing of Gram-Negative Bacteria Isolated from Blood Cultures.
    Patel YA; Kirn TJ; Weinstein MP; Uprety P
    Microbiol Spectr; 2021 Dec; 9(3):e0183621. PubMed ID: 34937177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens.
    Marschal M; Bachmaier J; Autenrieth I; Oberhettinger P; Willmann M; Peter S
    J Clin Microbiol; 2017 Jul; 55(7):2116-2126. PubMed ID: 28446572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.